Close
Back to NGM Stock Lookup

NGM Biopharmaceuticals (NGM) – Hot FDA News

Oct 17, 2022 07:35 AM NGM Biopharmaceuticals (NGM) CATALINA Phase 2 Trial of NGM621 Did Not Meet its Primary Endpoint
May 24, 2021 07:00 AM NGM Biopharmaceuticals (NGM) Phase 2b ALPINE 2/3 Study of Aldafermin in NASH Did Not Meet Primary Endpoint
Feb 24, 2020 08:09 AM

Back to NGM Stock Lookup